Orange Book product · Brand (NDA)
UPTRAVI
SELEXIPAG
At a glance
Dec 21, 2015
Approved
Brand (NDA)
Application
AB
TE code
12
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 21, 2015
10 yr 8 mo ago
Today
Patent 7205302 expires
Listed drug substance patent expiration.
Oct 31, 2026
in 4 mo
Patent 7205302*PED expires
Listed listed patent expiration.
Apr 30, 2027
in 11 mo
Patent 9173881 expires
Listed method-of-use patent (U-1798) expiration.
Aug 12, 2029
in 3 yr 2 mo
Patent 9173881*PED expires
Listed listed patent expiration.
Feb 12, 2030
in 3 yr 8 mo
Patent 9284280 expires
Listed method-of-use patent (U-1831) expiration.
Jun 25, 2030
in 4 yr 1 mo
Patent 8791122 expires
Listed drug substance patent expiration.
Aug 01, 2030
in 4 yr 2 mo
Patent 9284280*PED expires
Listed listed patent expiration.
Dec 25, 2030
in 4 yr 7 mo
Patent 8791122*PED expires
Listed listed patent expiration.
Feb 01, 2031
in 4 yr 8 mo
Patent 10821108 expires
Listed drug product patent expiration.
Dec 01, 2036
in 10 yr 7 mo
Patent 10828298 expires
Listed drug product patent expiration.
Dec 01, 2036
in 10 yr 7 mo
Patent 10821108*PED expires
Listed listed patent expiration.
Jun 01, 2037
in 11 yr 1 mo
Patent 10828298*PED expires
Listed listed patent expiration.
Jun 01, 2037
in 11 yr 1 mo
Pharmaceutical detail
Active ingredient
SELEXIPAG
Strength
0.2MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 207947
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (12)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7205302 | Oct 31, 2026 | in 4 mo | SubstanceProductU-1797 |
| 7205302*PED | Apr 30, 2027 | in 11 mo | |
| 9173881 | Aug 12, 2029 | in 3 yr 2 mo | U-1798 |
| 9173881*PED | Feb 12, 2030 | in 3 yr 8 mo | |
| 9284280 | Jun 25, 2030 | in 4 yr 1 mo | U-1831 |
| 8791122 | Aug 01, 2030 | in 4 yr 2 mo | SubstanceProduct |
| 9284280*PED | Dec 25, 2030 | in 4 yr 7 mo | |
| 8791122*PED | Feb 01, 2031 | in 4 yr 8 mo | |
| 10821108 | Dec 01, 2036 | in 10 yr 7 mo | ProductU-2992 |
| 10828298 | Dec 01, 2036 | in 10 yr 7 mo | ProductU-2991 |
| 10821108*PED | Jun 01, 2037 | in 11 yr 1 mo | |
| 10828298*PED | Jun 01, 2037 | in 11 yr 1 mo |
